Form D Flow: Medite Cancer Diagnostics $3.00 million Fundraising. David E Patterson Released Nov 3 form

Health Care Medite Cancer Diagnostics, Inc. - David E Patterson

Medite Cancer Diagnostics Financing

Medite Cancer Diagnostics, Inc., Corporation just released form D about $3.00 million equity financing. The date of first sale was 2016-10-18. Medite Cancer Diagnostics was able to sell $400,000 so far. That is 13.33% of the fundraising offer. The total offering amount was $3.00 million. The financing form was filed on 2016-11-03. The reason for the financing was: 7% cash commission + 3,000,000 warrants exercisable at .50 per share.. The fundraising still has about $2.60 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Medite Cancer Diagnostics is based in Florida. The firm’s business is Other Health Care. The SEC form was signed by David E Patterson Chief Executive Officer. The company was incorporated more than five years ago. The filler’s address is: 4203 Sw 34Th St, Orlando, Fl, Florida, 32811. David Eugene Patterson is the related person in the form and it has address: 4203 Sw 34Th Street, Orlando, Fl, Florida, 32811. Link to Medite Cancer Diagnostics Filing: 000141588916007331.

Analysis of Medite Cancer Diagnostics Offering

On average, companies in the Other Health Care sector, sell 68.60% of the total offering size. Medite Cancer Diagnostics sold 13.33% of the offering. The fundraising is still open. The average investment size for companies in the Other Health Care industry is $1.16 million. The offering was 65.52% smaller than the average of $1.16 million. Of course this should not be interpreted as negative. Firms get financed for different reasons and needs. The minimum investment for this financing was set at $50000. If you know more about the reasons for the financing, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Medite Cancer Diagnostics Also

The Form D signed by David E Patterson might help Medite Cancer Diagnostics, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment